# Re-ALK

> Medical app for ALK-rearranged NSCLC management, patient adherence, and doctor-patient communication. (iPhone/iPad app by Sowlutions Inc..)

- Source: https://appshunter.io/ios/app/re-alk/id6444945885 (this page in markdown: same URL + `.md`)
- Developer: [Sowlutions Inc.](https://appshunter.io/developer/1647391890)
- Category: Medical
- Price: Free
- Rating: 5.00/5 from 1 App Store ratings
- Age rating: 17+
- Requires: iOS 13.0 · 45 MB
- Languages: English
- Released: 2023-01-26
- Data updated: 2026-06-10
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/re-alk/id6444945885/reviews.md

## What is Re?

Re-ALK is created to improve the quality of ALK-rearranged Non-Small Cell Lung Cancer management through better practices and patients’ adherence. It is used to give scientific content for both doctors and patients. It also opens a forum of discussion for both patients and doctors. Patients can set reminders for their treatment and report adverse events on a regular basis. Doctors can receive adverse events reports from their patients and track them over time. They can also access decisional algorithms for different treatment lines.

## Key features

- Scientific content for doctors and patients
- Discussion forum
- Treatment reminders
- Adverse event reporting
- Decisional algorithms for treatment


## Frequently asked questions about Re

### What is Re-ALK used for?

Re-ALK is designed to improve the management of ALK-rearranged Non-Small Cell Lung Cancer. It provides scientific content, a discussion forum, treatment reminders, and adverse event reporting for both doctors and patients.

### Is Re-ALK free to use?

Yes, Re-ALK is available for free. It does not have any associated costs for download or use.

### Does Re-ALK have ads?

No, Re-ALK does not contain advertisements. Users can access its features without interruption from ads.

### What devices does Re-ALK support?

Re-ALK is currently supported on iPhone and iPod devices.

### How often is Re-ALK updated?

Re-ALK was last updated on January 27, 2023, with version 1.1.1. The release date was January 26, 2023.

### What is the age rating for Re-ALK?

Re-ALK has an age rating of 17+, indicating it is intended for mature audiences.

### Can patients report adverse events with Re-ALK?

Yes, patients can use Re-ALK to set reminders for their treatment and report adverse events on a regular basis. Doctors can then receive and track these reports.

### What kind of content does Re-ALK offer for doctors?

For doctors, Re-ALK offers scientific content related to ALK-rearranged Non-Small Cell Lung Cancer and access to decisional algorithms for different treatment lines.

## Version history (last 2 releases)

### 1.1.1 — 2023-01-27

Bug fixes

### 1.1 — 2023-01-26

No release notes.

## Apps similar to Re

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [东莞健安医药](https://appshunter.io/ios/app/id1639081500) | — | Free | Medical |
| [ポケット埼歯](https://appshunter.io/ios/app/id1660164060) | — | Free | Medical |
| [ihmsonline](https://appshunter.io/ios/app/ihmsonline/id1660390700) | — | Free | Medical |
| [TUA Member](https://appshunter.io/ios/app/tua-member/id1634143140) | — | Free | Medical |
| [Prescribing Companion App](https://appshunter.io/ios/app/prescribing-companion-app/id1643880020) | — | Free | Medical |
| [牙荷-商家](https://appshunter.io/ios/app/id1637593140) | — | Free | Medical |

## More apps by Sowlutions Inc.

- [POPS Admin](https://appshunter.io/ios/app/pops-admin/id1346619065)
- [POPS Logger](https://appshunter.io/ios/app/pops-logger/id1346619196)
- [Fabriq: Stay in Touch](https://appshunter.io/ios/app/fabriq-stay-in-touch/id1460143202)
- [Ur My Type - Dating. Friends.](https://appshunter.io/ios/app/ur-my-type-dating-friends/id1548164389)

All apps by Sowlutions Inc.: https://appshunter.io/developer/1647391890

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*